APP and Alzheimer disease: Although there are genetically-defined subgroups at high risk for AD, for example, patients with highly penetrant, autosomal dominant APP, PS1 or PS2 mutations,[1] late-onset AD generally is viewed as a heterogenous disease with multiple genetic, medical and environmental risk factors [2, 41].